Primary autoimmune thrombocytopenia in pregnancy: maternal and neonatal outcomes

Basit Öğe Kaydı
dc.contributor.authorEker, Turnagül
dc.contributor.authorÖkmen, Fırat
dc.contributor.authorSarıtaş, Didem Gül
dc.contributor.authorEkici, Hüseyin
dc.contributor.authorİmamoğlu, Metehan
dc.contributor.authorErgenoğlu, Ahmet Mete
dc.date.accessioned2024-08-25T18:38:16Z
dc.date.available2024-08-25T18:38:16Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractAim: To evaluate clinical characteristics, maternal and neonatal outcomes among pregnant women with primary autoimmune thrombocytopenia (ITP). Materials and methods: All pregnant women with ITP who had undergone antenatal follow-up and delivery at the Department of Obstetrics and Gynecology at a referral center, between 2011 and 2021, were retrospectively investigated. Patients were evaluated in three groups according to antenatal treatment modality. Results: 42 pregnant women with ITP were included in the study. A total of 29 (%69) pregnant women had been diagnosed with ITP before pregnancy and 13(%31) were diagnosed during pregnancy. 17 (%41) pregnant women did not receive any antenatal treatment, and 25 (%59) pregnant women receieved treatment. Postpartum haemorrhage (%50) was reported more frequently in the steroids+IVIG group. A total of 42 pregnancies, 43 babies (one twin pregnancy, 41 singletons) were liveborn. Three neonates (%7) had thrombocytopenia and one of them had intracranial haemorrhage. Conclusions: In pregnancies complicated with ITP, the platelet count is moderately or severely low, which can have adverse maternal and neonatal outcomes. Postpartum haemorrhage is a significant cause of maternal morbidity in cases with ITP. Therefore, pregnant women with ITP should be delivered in facilities that can adequately manage postpartum haemorrhage.en_US
dc.identifier.endpage80en_US
dc.identifier.issn1016-9113
dc.identifier.issn2147-6500
dc.identifier.issue1en_US
dc.identifier.startpage74en_US
dc.identifier.trdizinid1159006en_US
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1159006
dc.identifier.urihttps://hdl.handle.net/11454/100937
dc.identifier.volume62en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofEge Tıp Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240825_Gen_US
dc.subjectPrimary autoimmune thrombocytopeniaen_US
dc.subjectneonatal thrombocytopeniaen_US
dc.subjectpregnancyen_US
dc.subjectantenatal treatment.[Primer otoimmün trombositopenien_US
dc.subjectneonatal trombositopenien_US
dc.subjectgebeliken_US
dc.subjectantenatal tedavi.en_US
dc.titlePrimary autoimmune thrombocytopenia in pregnancy: maternal and neonatal outcomesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu